Description
A PPARγ-sparing thiazolidinedione derivative; binds only weakly to PPARγ (IC50 = 18.25 µM) and induces minimal activation of a Gal4-PPARγ reporter construct at 50 µM; decreases the pyruvate-induced oxygen consumption rate in control mitochondria but not in LS-Mpc2-/- mitochondria; reduces body weight gain and adiposity, as well as increases intrascapular BAT mass in a mouse model of NASH; reverses hepatic fibrosis and stellate cell fibrinogenesis in a mouse model of NASH; decreases plasma glucose, triglyceride, and cholesterol levels in ob/ob mice and increases insulin sensitivity in the striatal muscle, adipose tissue, and liver of diet-induced obese mice
Formal name: 5-[[4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
Synonyms:
Molecular weight: 371.4
CAS: 1133819-87-0
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Endocrinology & Metabolism|Thermogenesis